Net profit of Bal Pharma rose 270.83% to Rs 1.78 crore in the quarter ended December 2025 as against Rs 0.48 crore during the previous quarter ended December 2024. Sales rose 19.88% to Rs 87.69 crore in the quarter ended December 2025 as against Rs 73.15 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales87.6973.15 20 OPM %10.8810.59 - PBDT5.023.25 54 PBT1.790.57 214 NP1.780.48 271 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Bal Pharma declined 31.73% to Rs 0.71 crore in the quarter ended September 2025 as against Rs 1.04 crore during the previous quarter ended September 2024. Sales rose 0.45% to Rs 74.02 crore in the quarter ended September 2025 as against Rs 73.69 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales74.0273.69 0 OPM %7.7410.44 - PBDT2.993.84 -22 PBT0.721.36 -47 NP0.711.04 -32 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Bal Pharma announced that the 38th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News